Dolutegravir
성인

성인

HIV infection, Treatment-naïve or integrase strand inhibitor-naïve 50 mg PO once daily

HIV infection, INSTI-experienced with resistance substitutions 50 mg PO twice daily

HIV infection, In combination with Rilpivirine to replace current stable ARV regimen Dolutegravir 50 mg PO once daily + Rilpivirine 25 mg PO once daily

HIV infection, Non-occupational exposure, Prophylaxis Dolutegravir 50 mg PO once daily + Emtricitabine 200 mg/ Tenofovir disoproxil fumarate 300 mg PO once daily (for 28d)

Tablets and tablets for oral suspension are not interchangeable